Home
→
Ethiopian Food and Drug Authority (EFDA)
→
General reference materials
→
Reports and bulletins
→
Browsing Reports and bulletins by Issue Date

Browsing Reports and bulletins by Issue Date

Now showing items 1-19 of 19

Report on cohort event monitoring (CEM) of Dolutegravir containing ART regimens in selected health facilities of Addis Ababa, Ethiopia

Ethiopian Food and Drug Authority (2023)

Even though the introduction of DTG based ART has provided a potent treatment option for persons living with HIV, there is growing evidence from clinical settings that use of DTG can result in hyperglycemia, serious ...
Single-dose oral bioequivalence study of Primaquine 15 mg tablet (test product) and Primaquine 15 mg tablet (reference product) in healthy adult human subjects under fasting conditions

Ethiopian Food and Drug Authority (2024)

WHO prequalification offers the possibility of a line extension based on demonstrating proportionality with the adult 15 mg tablet. For a generic manufacturer, a bioequivalence study must be performed comparing the generic ...
Effectiveness of an integrated program for the prevention of rheumatic heart disease in endemic regions: an incomplete stepped wedge cluster randomized trial

Ethiopian Food and Drug Authority (2024)

Timely detection and treatment of Group A beta-hemolytic streptococcal infections (GAHBS) pharyngitis among children represents an effective target for primary prevention of Rheumatic heart disease (RHD). To study different ...
A revised Tafenoquine dose to improve radical cure for Vivax malaria -Tafenoquine dosing revised

Ethiopian Food and Drug Authority (2024)

Tafenoquine (TQ), as a single dose regimen, has significant advantages over the longer courses of primaquine (PQ) needed to achieve radical cure of P. vivax. The current data available show that the recommended fixed ...
Guideline for consumer reporting of adverse event of medicines

Ethiopian Food and Drug Authority (2024)

a consumer in healthcare is anyone; patient or client or family; who uses, has used, or may use any health or health related service. It is not limited to those currently using a service. Consumer report: is a report of ...
Feasibility, safety and efficacy of concomitant curcumin in patients undergoing palliative radiotherapy for FIGO stage IIIB–IVA cervical cancer: An open-label pilot trial

Ethiopian Food and Drug Authority (2024)

The rationale for combining curcumin with radiotherapy in the context of treating stage IIIB-IVA cervical cancer aims to enhance therapeutic efficacy while mitigating treatment related toxicities. Envisaged synergies ...
Assessing new paediatric tablets of primaquine as radical cure in Ethiopia.

Ethiopian Food and Drug Authority (2024)

Drug formulations that children are able to use and comfortable to take type has been overlooked for many years. The availability of pediatric drugs in the right doses, taste and odour/flavour is critically important. ...
Graft of Autologous minimally manipulated homologous adipose (AMHAT) treatment of chronic wound, DFU

Ethiopian Food and Drug Authority (2024)

Diabetic foot ulcers (DFUs) are a significant public health concern in Ethiopia, with a prevalence rate of 12.98% among diabetic patients. The highest prevalence is observed in Addis Ababa, with a rate of 19.31%. DFUs ...
Serological testing and treatment for plasmodium vivax malaria: A cluster-randomized trial in Ethiopia

Ethiopian Food and Drug Authority (2025)

The resilience of P. vivax to malaria elimination efforts is due to its ability to form dormant liver stages (hypnozoites) that reactivate weeks to months after the initial infection causing recurrent episodes of ...
Pharmacovigilance newsletter

Ethiopian Food and Drug Authority (2025)

The Ethiopian Food and Drug Authority in collaboration with its partners, successfully conducted a four-day Pharmacovigilance Data Management and Analysis Training from July 17–20, 2025, in Adama Town, Ethiopia. ...
Peer-led HIV care and the UNAIDS 90-90-90 treatment targets in Sidama Ethiopia: A cluster randomized trial and economic evaluation of Teach-Test- Link-Trace model (TTLT) trial

Ethiopian Food and Drug Authority (2025)

This study aims to test a new and comprehensive intervention program, never been implemented in Ethiopia before, called the teach-test-link-trace (TTLT) model. The TTLT model involves HIV positive volunteer patients (peer ...
Medicine information bulletin, Volume 2, Issue 1, June 2025

Ethiopian Food and Drug Authority (2025)

The MOH plans to pilot it in selected health facilities. In parallel, it is essential to create public awareness about the availability of DMPA-SC, self-administration technique, and its potential benefit in ...
Medicine information bulletin, Volume 2, Issue 2, October 2025

Ethiopian Food and Drug Authority (2025)

LEN is given as a 927 mg subcutaneous injection every six months. Patients must be confirmed HIV-negative before the first and each subsequent dose. The injection is administered by a trained health professional under ...
Guideline for good clinical practice, version 004

Ethiopian Food and Drug Authority (2025-06)

Good Clinical Practice is an international ethical and scientific standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials. Clinical trials conducted in ...
EFDA voice, October 2025

Ethiopian Food and Drug Authority (2025-10)

This success showcases the Ethiopian Food and Drug Authority's (EFDA) relentless dedication to protecting public health through its guarantee that imported medicines and vaccines meet international standards of quality, ...
Guideline for emergency use authorization of vaccines and therapeutics for Marburg Virus Disease

Ethiopian Food and Drug Authority (2025-11)

Marburg virus disease (MVD) is a severe hemorrhagic fever with case fatality rates that can exceed 80%. The disease is caused by Marburg virus (MARV), a filovirus closely related to Ebola virus. Outbreaks are rare but ...
Guideline for drug information services

Ethiopian Food and Drug Authority (Dec 2025)

Reliable, timely, and evidence-based drug information (DI) is vital to patient safety, rational medicine use, and regulatory decision-making. In Ethiopia, gaps in access to high-quality DI Services (DIS) contribute to ...
Operational feasibility of appropriate radical cure of Plasmodium vivax with tafenoquine or primaquine after semi-quantitative G6PD testing in Ethiopia: a mixed methods study

Ethiopian Food and Drug Authority (Feb 2024)

Primaquine (PQ) and tafenoquine (TQ) can be used for the radical cure (RC) of P. vivax malaria. PQ requires a 14-day dose, compared to a single-day dose for TQ, which is likely to improve patient adherence to the treatment. ...
A phase I clinical investigation to the safety of two herbal ointment formulations for an intended treatment of Tinea corporis/cruris

Ethiopian Food and Drug Authority (May 2025)

Traditional medicine is an integral part of the local culture in Ethiopian context and used by the majority of the population regardless of the incremental expansion and accessibility of modern health services. A prevalence ...

Browsing Reports and bulletins by Issue Date

Browsing Reports and bulletins by Issue Date

Search IPHC-E Repository

Browse

All of IPHC-E

This Collection

My Account